Related Experiment Video
Updated: Feb 10, 2026

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
Published on: June 2, 2022
Generation of High Expressing Chinese Hamster Ovary Cell Pools Using the Leap-In Transposon System
Sowmya Balasubramanian1, Robert B Peery2, Jeremy Minshull3
1Bioprocess Research and Development, Eli Lilly and Company, LTC-North, 1200 Kentucky AvenueIndianapolis, IN, 46221, USA.
Abstract:
Clonally derived cell lines (CDCL) from Chinese Hamster Ovary (CHO) host cell lines, remain the most popular method to manufacture therapeutic proteins. However, CHO cell pools are increasingly being used as an alternate method to produce therapeutic proteins for preclinical drug development in an effort to shorten the time required for new drug development. It is essential that these CHO pools exhibit the desired attributes of CHO CDCLs such as high protein titers and consistent product quality attributes (PQAs). In this study the authors evaluated the Leap-In Transposase®, for the expression of four different proteins (three mAbs and one Bispecific mAb). The resultant pool titers ranges from 2.0 to 5.0 g L-1 for the four proteins compared to 1.5-3.3 g L-1 from the respective control pools (generated by random gene integration). The resultant cell pools are a homogeneously expressing cell population. The average gene copy numbers are similar or lower in the evaluation pools relative to the control pools. The higher titers in the evaluation pools are attributed to higher levels of both IgG-LC and IgG-HC mRNA. In conclusion, the Leap-In transposase generates high titer, homogeneous CHO pools in a short time-period without introducing any undesired PQAs.
Insights
The Leap-In Transposase efficiently generates high-titer Chinese Hamster Ovary (CHO) cell pools for therapeutic protein production. This method accelerates preclinical development by creating homogeneous cell populations with consistent product quality attributes.
Area of Science:
- Biotechnology
- Bioprocessing
- Molecular Biology
Background:
- Clonally derived cell lines (CDCL) from Chinese Hamster Ovary (CHO) are standard for therapeutic protein manufacturing.
- CHO cell pools offer a faster alternative for preclinical drug development.
- Ensuring CHO pools match CDCLs in protein titers and product quality is crucial.
Purpose of the Study:
- To evaluate the Leap-In Transposase system for generating high-titer, homogeneous CHO cell pools.
- To assess if Leap-In Transposase impacts product quality attributes (PQAs).
Main Methods:
- The Leap-In Transposase system was used to express four different proteins (three mAbs, one Bispecific mAb) in CHO cells.
- Resulting cell pools were analyzed for protein titers, homogeneity, and gene copy numbers.
- Comparison was made against control pools generated via random gene integration.
Main Results:
- Leap-In Transposase generated pool titers ranging from 2.0 to 5.0 g/L, exceeding control pool titers (1.5-3.3 g/L).
- The cell pools produced were homogeneously expressing.
- Higher titers were linked to increased IgG-LC and IgG-HC mRNA levels, with similar or lower gene copy numbers compared to controls.
Conclusions:
- The Leap-In Transposase is effective for rapidly generating high-titer, homogeneous CHO cell pools.
- This system accelerates therapeutic protein production without compromising product quality attributes.
- Leap-In Transposase offers a valuable tool for efficient preclinical drug development.
More Related Videos
10:50Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
Published on: May 1, 2019
07:13Developing Custom Chinese Hamster Ovary-host Cell Protein Assays using Acoustic Membrane Microparticle Technology
Published on: February 3, 2011
Related Concept Videos
DNA-only Transposons
The donor site from where the transposon is excised is either degraded or...
Transposons
Ovaries
On the ovarian surface, a layer of...
Cell Specific Gene Expression
Cell Specific Gene Expression
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...